+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain



Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain



Chinese Medical Journal 117(11): 1625-1629



Background The etiologic agent of severe acute respiratory syndrome (SARS) has been confirmed to be a novel coronavirus (CoV), namely SARS-CoV. Developing safe and effective SARS-CoV vaccines is essential for us to prevent the possible reemergence of its epidemic. Previous experiences indicate that inactivated vaccine is conventional and more hopeful to be successfully developed.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 012161459

Download citation: RISBibTeXText

PMID: 15569476


Related references

Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice. Clinical and Vaccine Immunology 16(1): 73-77, 2009

Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine. Journal of General Virology 85(Pt 10): 3109-3113, 2004

Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunology 122(4): 496-502, 2007

Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice. Clinical and Vaccine Immunology 14(7): 894-901, 2007

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Antiviral Therapy 12(7): 1107-1113, 2007

Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. Vaccine 23(24): 3196-3201, 2005

Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. Journal of Virology 88(15): 8597-8614, 2014

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. Journal of Virology 85(23): 12201-12215, 2011

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology 85(9): 4122-4134, 2011

Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. Journal of Virology 82(19): 9465-9476, 2008

Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochemical and Biophysical Research Communications 327(1): 130-135, 2005

Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. Journal of Infectious Diseases 193(9): 1244-1249, 2006

Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. Plos one 5(1): E8729, 2010

Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses. Immunity and Ageing 11(1): 4, 2014

Immune response in Balb/c mice induced by recombinant spike protein of severe acute respiratory syndrome coronavirus. Chinese Medical Journal 118(10): 857-860, 2005